StockNews.AI
SNY
StockNews.AI
89 days

VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc. - VIGL

1. Sanofi proposes to acquire Vigil Neuroscience for $8.00 per share. 2. Vigil shareholders may receive an additional $2.00 contingent on VG-3927 sales. 3. KSF is investigating if the acquisition undervalues Vigil Neuroscience. 4. The sale's terms are being scrutinized by legal experts and investors.

3m saved
Insight
Article

FAQ

Why Bullish?

The acquisition price reflects a premium for Vigil's shareholders, indicating Sanofi's confidence in future growth.

How important is it?

The potential uplift in Sanofi’s portfolio directly correlates with the success of the Vigil acquisition.

Why Short Term?

Initial market reactions to acquisitions often affect stock prices quickly, as seen in past transactions.

Related Companies

VIGL
- NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Vigil Neuroscience, Inc. (NasdaqGS: VIGL) to Sanofi (NasdaqGS: SNY). Under the terms of the proposed transaction, shareholders of Vigil will receive $8.00 in cash for each share of Vigil that they own as well as a non-tradeable contingent value right entitling the holder to potentially receive an additional $2.00 per share in cash (payable following the first commercial sale of VG-3927 if achieved within a specific period). KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-vigl/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. More News From Kahn Swick & Foti, LLC

Related News